View in EDS

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Saved in:
Bibliographic Details
Title: Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Authors: Burm R; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Maravelia P; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Ahlen G; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Ciesek S; Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.; German Center for Infection Research, DZIF, External partner site, Frankfurt am Main, Germany., Caro Perez N; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Pasetto A; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Urban S; Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany., Van Houtte F; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Verhoye L; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Wedemeyer H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Johansson M; School of Medical Sciences, Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Orebro, Sweden., Frelin L; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Sällberg M; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden philip.meuleman@ugent.be matti.sallberg@ki.se., Meuleman P; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium philip.meuleman@ugent.be matti.sallberg@ki.se.
Source: Gut [Gut] 2023 Jun; Vol. 72 (6), pp. 1186-1195. Date of Electronic Publication: 2022 Aug 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35977815
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burm+R%22">Burm R</searchLink>; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Maravelia+P%22">Maravelia P</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ahlen+G%22">Ahlen G</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ciesek+S%22">Ciesek S</searchLink>; Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.; German Center for Infection Research, DZIF, External partner site, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Caro+Perez+N%22">Caro Perez N</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Pasetto+A%22">Pasetto A</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Urban+S%22">Urban S</searchLink>; Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Van+Houtte+F%22">Van Houtte F</searchLink>; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Verhoye+L%22">Verhoye L</searchLink>; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Wedemeyer+H%22">Wedemeyer H</searchLink>; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Johansson+M%22">Johansson M</searchLink>; School of Medical Sciences, Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Orebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Frelin+L%22">Frelin L</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Sällberg+M%22">Sällberg M</searchLink>; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden philip.meuleman@ugent.be matti.sallberg@ki.se.<br /><searchLink fieldCode="AU" term="%22Meuleman+P%22">Meuleman P</searchLink>; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium philip.meuleman@ugent.be matti.sallberg@ki.se.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985108R%22">Gut</searchLink> [Gut] 2023 Jun; Vol. 72 (6), pp. 1186-1195. <i>Date of Electronic Publication: </i>2022 Aug 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985108R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3288 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200175749%22">00175749 </searchLink><i>NLM ISO Abbreviation: </i>Gut <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35977815
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/gutjnl-2022-327216
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1186
    Titles:
      – TitleFull: Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burm R
      – PersonEntity:
          Name:
            NameFull: Maravelia P
      – PersonEntity:
          Name:
            NameFull: Ahlen G
      – PersonEntity:
          Name:
            NameFull: Ciesek S
      – PersonEntity:
          Name:
            NameFull: Caro Perez N
      – PersonEntity:
          Name:
            NameFull: Pasetto A
      – PersonEntity:
          Name:
            NameFull: Urban S
      – PersonEntity:
          Name:
            NameFull: Van Houtte F
      – PersonEntity:
          Name:
            NameFull: Verhoye L
      – PersonEntity:
          Name:
            NameFull: Wedemeyer H
      – PersonEntity:
          Name:
            NameFull: Johansson M
      – PersonEntity:
          Name:
            NameFull: Frelin L
      – PersonEntity:
          Name:
            NameFull: Sällberg M
      – PersonEntity:
          Name:
            NameFull: Meuleman P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3288
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Gut
              Type: main
ResultId 1